Ontario funding to support hundreds of research projects; the country’s first interdisciplinary training network in perinatal research on medications, and South Korean President Yoon Suk-yeol’s U of T visit to discuss the rise of artificial intelligence.
Topic: artificial intelligence in Canada
The Short Report – July 13, 2022: Dr. Mona Nemer reappointed as CSA, U of T & partners mount research response to monkeypox outbreak, a record for Canadian angel investment in 2021, and more.
A new term for Dr. Mona Nemer; U of T’s response to monkeypox outbreak paves the way for collaborations with Canadian and international groups, a rebound in Canadian angel investment stats, and more.
The Short Report – June 1, 2022: IBM boosts research and innovation at Memorial U; formalizing a framework for AI and data science research, Ottawa supports a national energy modelling hub, and more.
IBM invests to strengthen research and innovation in Newfoundland and Labrador; a framework to deepen links between the NRC and Canada’s AI research and industry ecosystem, an energy hub to connect modellers and policymakers, and more.
The Short Report: Jan. 19, 2022: $550M in federal research investments, a review of Canada’s energy policies, COVID-19’s impacts on children, and more
Ottawa announces over $550 million in federal research investments, the International Energy Agency reviews Canada’s energy policies, an international study details COVID-19’s impacts on children, MDA wins a second contract for a 2023 moon mission, and more.
The Short Report – Dec. 8, 2021: Ontario launches flagship EV program, Alberta boosts vaccine development capacity, applied research on the rise, and more
The launch of Ontario’s vehicle innovation network signals readiness for next-generation auto solutions, Alberta invests tens of millions of dollars to fund vaccine research and manufacturing capacity, research activity continues to grow at colleges and institutes across Canada, and more.
Opinion Leader: Canada’s early focus on artificial intelligence is starting to reap commercial benefits
Canada’s early contributions and long-standing academic expertise in artificial intelligence are now generating growing funding for and revenue in AI in drug development, but the country’s AI-enabled drug development industry faces significant challenges in coming years, Dr. Ulrik Kristensen, PhD, founder and principal analyst at UK-based Emersion Insights, says in an op-ed.